Zusammenfassung
Die meisten pulmonalen Erkrankungen des Neugeborenen (s. auch S.119) gehen mit Atemnot einher:
-
Tachypnoe über 60/min (= Aufrechterhaltung eines normalen Atemzeitvolumens trotz hohen Atemwegswiderstands),
-
sternale Einziehungen (= vermehrte Retraktionskraft der Lunge durch erhöhte Oberflächenspannung bei noch weichem Thoraxskelett),
-
exspiratorisches Stöhnen (= verbesserter Gasaustausch durch Hinauszögern des alveolären Kollapses),
-
Nasenflügeln (= Einsatz der auxiliären Atemmuskulatur).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Abman SH, Wolfe RR, Accurso FJ, Koops BL, Bowman M, Wiggins JW (1985) Pulmonary vascular response to oxygen in infants with severe bronchopulmonary dysplasia. Pediatrics 75: 80–87
Avery ME, Fletcher BD (1981) The lung and its disorders in the newborn infant, 4th ed. Saunders, Philadelphia
Avery GB, Fletcher AB, Kaplan M, Brudno DS (1985) Controlled trial of dexamethasone in respirator-dependent infants with bronchopulmonary dysplasia. Pediatrics 75:106–111
Avery ME, Tooley WH, Keller JB, et al. (1987) Is chronic lung disease in low birth weight infants preventable? A survey of eight centers. Pediatrics 79: 16–30
Bacsik RD (1977) Meconium aspiration syndrome. Pediatr Clin North Am 24: 463
Banayale RC, Outerbridge EW, Aranda JV (1974) Lung perforation: a complication of chest tube insertions in neonatal pneumothorax. J Pediatr 94: 973
Bancalari E, Abdenour GE, Feller R, Gannon J (1979) Bronchopulmonary dysplasia: clinical presentation. J Pediatr 95: 819
Bell EF, Warburton D, Stonestreet BS, Oh W (1980) Effect of fluid administration on the development of symptomatic patent ductus arteriosus and congestive heart failure in premature infants. N Engl J Med 302: 598–604
Bertrand J, Riley SP, Popkin J, et al. (1985) The long-term pulmonary sequelae of prematury: the rate of familial airway hyperreactivity and the respiratory distress syndrome. N Engl J Med 312: 742–745
Bonikos DS, Bensch KG, Northway HW, Edwards DK (1976) Bronchopulmonary dysplasia: The pulmonary pathologic sequelae of necrotizing bronchiolitis and pulmonary fibrosis. Hum Pathol 7: 643
Brown ER (1979) Increased risk of bronchopulmonary dysplasia in infants with patent ductus arteriosus. J Pediatr 95: 865
Carson BS, Losey RW, Bowes WA, Simmons MA (1976) Combined obstetric and pediatric approach to prevent meconium aspiration syndrome. Am J Obstet Gynecol 126: 712–715
Clark DA (1982) HLA-A2 and chronic lung disease in neonates. JAMA 248: 1868
Cohen RS, Stevenson DK, Malachowski N, et al. (1982) Favourable results of neonatal intensive care for very low birthweight infants. Pediatrics 69: 621–625
Cooney DR, Menke JA, Allen RE (1977) „Acquired“ lobar emphysema: a complication of respiratory distress in premature infants. J Pediatr Surg 12: 897
De Vito JM, et al. (1983) Furosemide-associated ototoxicity. Clin Pharm 2: 507–508
Doyle LW, Kitchen WH, Ford GW, Rickards AL, Lissendew JV, Ryan MM (1986) Effects of antenatal steroid therapy on mortality and morbidity in very low birth weight infants. J Pediatr 108: 287–292
Edwards DK, Colby TY, Northway WH (1979) Radiographic-patho-logic correlation in bronchopulmonary dysplasia. J Pediatr 95: 834
Ehrenkranz RA, Bonta BW, Ablow RC, Warshaw JB (1978) Amelioration of bronchopulmonary dysplasia after vitamin E administration. A preliminary report. N Engl J Med 299: 564
Escobedo MB, Gonzales A (1976) Bronchopulmonary dysplasia in the tiny infant. Clin Perinat 13: 315–326
Frank L, Anton AP, Roberts RJ (1977) Oxygen therapy and hyaline membrane disease: the effect of hyperoxia on pulmonary superoxide dismutase activity and the mediating role of plasma or serum. J Pediatr 90: 105
Fujiwara T, Chida S, Watabe Y, Maeta H, Morita T, Abe T (1980) Artificial surfactant therapy in hyaline membrane disease. Lancet I: 55
Geggel RL, Pereia GR, Spackman TJ (1978) Fractured ribs: unusual presentation of rickets in premature infants. J Pediatr 93: 680
Giedion A, Haeflinger H, Dangel P (1973) Acute pulmonary x-ray changes in hyaline membrane disease treated with artificial ventilation and positive endexpiratory pressure. Pediatr Radiol 1:145
Gitlin JD, Soll RF, Parad RB, et al. (1987) Randomized controlled trial of exogenous surfactant for the treatment of hyaline membrane disease. Pediatrics 79: 31–37
Gluck L, Kulovich MV (1973) Lecithin/sphingomyelin ratio in amniotic fluid in normal and abnormal pregnancy. Am J Obstet Gynecol 115: 593
Sherman E, Aeberhard E, Barrett C (1988) Surfactant treatment of newborn rabbits impedes intrapulmonary phagocytic killing of inhaled group B streptococci. In: Lachmann B (ed) Surfactant replacement therapy in neonatal and adult respiratory distress syndrome. Springer, Berlin Heidelberg New York
Gottfried AW, Gaiter JL (1985) Infant stress under intensive care. University Park Press, Baltimore
Hallman M, Feldman BH, Kirkpatrick E, Gluck L (1977) Absence of phosphatidylglycerol in respiratory distress syndrome in the newborn. Pediatr Res 11: 714
Hallman M, Merritt TA, Jarvenpää AL, et al. (1985) Exogenous human surfactant for the treatment of severe respiratory distress syndrome: a randomized, prospective clinical trial. J Pediatr 106: 963–969
Hatch DJ, Sumner E (1986) Neonatal anesthesia and perioperative care, 2nd edn. Arnold, London, pp 161–163
Hill A, Perlman JM, Volpe JJ (1982) Relationship of pneumothorax to occurrence of intraventricular hemorrhage in the premature newborn. Pediatrics 69:144
Hjalmarson O (1981) Epidemiology and classification of acute neonatal respiratory disorders. A prospective study. Acta Paediatr Scand 70: 773–783
Hufnagle KG, Khan SN, Penn D, et al. (1982) Renal calcifications: a complication of long-term furosemide therapy in preterm infants. Pediatrics 70:360–363
Kao LC, Warburton D, Sorgent CW (1983) Furosemide acutely decreases airway resistance in chronic bronchopulmonary dysplasia. J Pediatr 103: 624
Kao LC, Warburton D, Cheng MH, Cedeno C, Platzker ACG, Keens TG (1984) Effect of oral diuretics on pulmonary mechanics in infants with chronic bronchopulmonary dysplasia: results of a double-blind crossover sequential trial. Pediatrics 74: 37–44
Koops BL, Abman SH, Accurso FJ (1984) Outpatient management and follow-up of bronchopulmonary dysplasia. Clin Perinatol 11:101–122
Kuhns LR, Bednarek FJ, Wyman ML, Roloff DW, Borer RC (1975) Diagnosis of pneumothorax or pneumomediastinum in the neonate by transillumination. Pediatrics 56: 355
Kwong MS, Egan EA (1986) Reduced incidence of hyaline membrane disease in extremely premature infants following delay of delivery in mother with premature labor: use of Ritodrine and Betamethasone. Pediatrics 78: 767–774
Liggins GC, Howie RN (1972) A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 50: 515
Long JG, Philip AGS, Lucey JF (1980) Excessive handling as a cause of hypoxemia. Pediatrics 65: 203
Mannino FL, Feldman BH, Heldt GP, De Lue NA, Wimmer JE, Fletcher MA, Gluck L (1976) Early mechanical ventilation in RDS with a prolonged inspiration. Pediatr Res 10: 464
Mammel MC, Green TP, Johnson DE, Thompson TR (1983) Controlled trial of dexamethasone therapy in infants with bronchopulmonary dysplasia. Lancet 1:1356–1358
Mayes L, Perke HE, Stahlman MT (1983) Severe bronchopulmonary dysplasia: a retrospective review. Acta Paediatr Scand 72: 225
Meisels SJ, Plunkett JW, Roloff DW, Pasick PL, Stiefel GS (1986) Growth and development of preterm infants with respiratory distress syndrome and bronchopulmonary dysplasia. Pediatrics 77: 345–352
Meyer E, Obladen M (1986) Unbeabsichtigte Pericardpunktion mit einem Mathys-Katheter. Pädiatr Prax 33: 121–123
Monin P, Vert P (1987) The management of bronchopulmonary dysplasia. Clin Perinatol 14: 531–549
Morley CJ (1987) The Cambridge experience of artificial surfactant. In: Walters DV, Strong LB, Geubelle G (eds) Physiology of the fetal and neonatal lung. MTP Press, Lancaster, pp 255–274
Nelson LH, Meis PJ, Hatjis CG, et al. (1985) Premature rupture of membranes: a prospective randomized evaluation of steroids, latent phase, and expectant management. Obstet Gynecol 66: 55–58
Nishibayashi SW, Andrassy RJ, Wolley MM (1981) Congenital cystic adenomatoid malformation: a 30 year experience. J Pediatr Surg 16: 704
Noack G, Berggren P, Curstedt T, et al. (1987) Severe neonatal respiratory distress syndrome treated with the isolated phospholipid fraction of natural surfactant. Acta Paediatr Scand 76: 697–705
Northway WH, Rosan RC, Porter DY (1967) Pulmonary disease following respirator therapy of hyaline membrane disease: bronchopulmonary dysplasia. N Engl J Med 276: 357
Obladen M (1978) Factors influencing surfactant composition in the newborn infant. Eur J Pediatr 128: 129
Obladen M, Stevens P, Kattner E (1988) Rapid response of oxygenation, slow response of compliance after liposomal phospholipid substitution in RDS. In: Lachmann B (ed) Surfactant replacement therapy in neonatal and adult respiratory distress syndrome. Springer, Berlin Heidelberg New York
Ogata ES, Gregory GA, Kitterman JA (1976) Pneumothorax in the respiratory distress syndrome. Pediatrics 58: 783
Pfenninger J, Bossi E, Biesoldy J, Blumberg A (1982) Treatment of pneumothorax, pneumopericardium and pneumomediastinum. Helv Paediatr Acta 37: 353
Perelman RH, Palta M, Kirby R, Farrell PM (1986) Discordance between male and female deaths due to the respiratory distress syndrome. Pediatrics 78: 238–244
Reynolds EOR (1974) Pressure waveform and ventilator settings for mechanical ventilation in severe hyaline membrane disease. Int Anesthe-siol Clin 12:259
Robert MF, Neff RK, Hubbell JP, Taeusch HW, Avery ME (1976) Association between diabetes and the respiratory distress syndrome in the newborn. N Engl J Med 294: 357
Rooklin AR, Moomjian AS, Shutack JG, Schwartz JG, Fox WW (1979) Theophylline therapy in bronchopulmonary dysplasia. J Pediatr 95: 882
Rosenfeld W, Evans H, Concepcion L, et al. (1984) Prevention of bronchopulmonary dysplasia by administration of bovine superoxide dismu-tase to preterm infants with respiratory distress syndrome. J Pediatr 105: 781–785
Saldanha RL, Cepeda EE, Poland RL (1982) The influence of vitamin E prophylaxis on the incidence and severity of bronchopulmonary dysplasia. J Pediatr 101: 89
Schmidt PL, Sims ME, Strassner NT, et al. (1984) Effect of antepartum glucocorticoid administration upon neonatal respiratory distress syndrome and perinatal infection. Am J Obstet Gynecol 148: 178–186
Stahlman MT, Cheatham W, Grey ME (1979) The role of air dissection in bronchopulmonary dysplasia. J Pediatr 95: 878
Stewart AL, Turcan DM, Rawlings G, Reynold EOR (1977) Prognosis for infants weighing 1000 g or less at birth. Arch Dis Child 52: 97
Strayer DS, Merritt TA, Lwebuga-Mukasa J, Hallman M (1986) Surfactant-anti-surfactant immune complexes in infants with respiratory distress syndrome. Am J Pathol 122: 353–362
Taeusch HW, Keough KMW, Williams M, et al. (1986) Characterization of bovine surfactant for infants with respiratory distress syndrome. Pediatrics 77: 572–581
Teaque WG, Heldt GP, Tooley WH (1986) Hypoxia causes bronchocon-striction in infants with chronic lung disease. Pediatr Res 20: 443
Toce SS, Farrell PM, Leavitt LA, Samuels DP, Edwards DK (1984) Clinical and roentgenographic scoring systems for assessing bronchopulmonary dysplasia. Am J Dis Child 138: 581–585
Tyler DC, Murphy J, Cheney FW (1978) Mechanical and chemical damage to lung tissue caused by meconium aspiration. Pediatrics 62: 454
Usher R (1987) Extreme prematurity. In: Avery GB (ed) Neonatology. Pathophysiology and management of the newborn, 3rd edn. Lippincott, Philadelphia, pp 264–298
Werthammer J, Brown ER, Neff RK, Taeusch HW (1982) Sudden infant death syndrome in infants with bronchopulmonary dysplasia. Pediatrics 69: 301
Wilkie RA, Bryan MH (1987) Effect of bronchodilators on airway resistance in ventilator-dependent neonates with chronic lung disease. J Pediatrl 11: 278–282
Wung JT, Koons AH, Driscoll JM, James LS (1979) Changing incidence of bronchopulmonary dysplasia. J Pediatr 95: 845
Wyszogrodski I, Kyei-Aboagye HW, Taeusch HW, Avery ME (1975) Surfactant inactivation by hyperventilation; conservation by end expiratory pressure. J Appl Physiol 38: 461
Yeh TF, Srinivasan G, Harris V, et al. (1977) Hydrocortisone therapy in meconium aspiration syndrome: a controlled study. J Pediatr 90: 140
Rights and permissions
Copyright information
© 1989 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Obladen, M. (1989). Pulmonale Erkrankungen. In: Neugeborenenintensivpflege. Kliniktaschenbücher. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-08939-2_8
Download citation
DOI: https://doi.org/10.1007/978-3-662-08939-2_8
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-50551-8
Online ISBN: 978-3-662-08939-2
eBook Packages: Springer Book Archive